PAX5 and precursor B-cell acute lymphoblastic leukemia: PAX5 fusions occur in approximately 2.5% of pediatric B-ALL patients and typically result in chimeric genes encoding proteins that retain the DNA-binding paired box domain (exons 1–4) of PAX5.